Претраживање
Приказ резултата 1-5 од 5
Evaluation of the Possible Contribution of Antioxidants Administration in Metabolic Syndrome
(Current Pharmaceutical Design, 2011)
The metabolic syndrome (MetS) is common, and its associated risk burdens of diabetes and cardiovascular disease (CVD) are a major public health problem. The hypothesis that main constituent parameters of the MetS share ...
Insulin, Thrombin, ERK1/2 Kinase and Vascular Smooth Muscle Cells Proliferation
(Current Pharmaceutical Design, 2010)
Vascular smooth muscle cells (VSMC) respond to arterial wall injury by intimal proliferation and play a key role in atherogenesis by proliferating and migrating excessively in response to repeated injury, such as hypertension ...
Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases
(Current Pharmaceutical Design, 2017)
Background: The sodium/potassium- adenosine- triphosphatase (Na+/K+-ATPase) is an important mediator in vasculature tone and contractility, and its abnormal regulation has been implicated in many diseases such as obesity, ...
A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
(Current Pharmaceutical Design, 2013)
Ghrelin is a peptide hormone produced mainly in the stomach that has widespread tissue distribution and diverse hormonal, metabolic and cardiovascular activities. The circulating ghrelin concentration increases during ...
Chronic Hepatitis C, Insulin Resistance and Vascular Disease
(Current Pharmaceutical Design, 2010)
The role of hepatitis C virus (HCV) infection in the development of vascular disease is controversial. Insulin resistance (IR) is a recognized risk factor for cardiovascular disease (CVD) and is associated with chronic ...